1. Lawsuit-ridden J&J tumbles in annual listing of best global brands — AstraZeneca gets Q2 2020 PDUFA date for breast cancer ADC — Shionogi's antibiotic clears FDA panel vote — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Aimovig Approval

Discussion in 'Depomed' started by anonymous, May 18, 2018 at 10:51 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    We are doomed (.)
     
  2. anonymous

    anonymous Guest

    Yup. Time to dust off my resume. The end is near. Writing is on the wall...
     
  3. anonymous

    anonymous Guest

    This drug is really expensive and cambia will still be a great alternative for migraine sufferers.
     
  4. anonymous

    anonymous Guest

    The drug is not any more expensive than Cambia. Plus it's a preventative. There will still be a need for acute therapies. Not competition.
     
  5. anonymous

    anonymous Guest

    Vow, now competitors trying to advertise here. Shortsellers bashing here. Funny.
     
  6. anonymous

    anonymous Guest

    The drug is cheap. It's less than 6 k a month. I paid more than that for a topical my daughter was one. many insurance approving Aimovig as it's so inexpensive for a biologic
     
  7. anonymous

    anonymous Guest

    less than 6 k a year